The Detroit Tigers made strategic decisions following their 2025 playoff appearance, aiming to compete effectively in 2026. Among their key moves was signing standout pitcher Framber Valdez, adding Kenley Jansen to fortify their bullpen, and offering Gleyber Torres a lucrative deal to retain his hitting power. Additionally, they secured top prospect Kevin McGonigle with a significant $150 million contract, ensuring his presence during his prime years. Crucially, they chose not to trade pitcher Tarik Skubal.
In 2025, Skubal captured his second Cy Young Award, enhancing his reputation as potentially the premier pitcher in baseball. His contract situation looms large, as he approaches free agency post-2026 season. Before his recent injury, he was projected to command a record-breaking pitcher contract, complicating prospects for a Detroit extension.
A significant title run could vindicate Skubal’s potential free agency loss. However, the Tigers have struggled mightily as June approaches. Skubal’s been out with an elbow injury since May. After a standout 2025, their positional players have delivered among the league’s weakest offensive and defensive performances in 2026, according to FanGraphs. While starting pitching remains slightly above average, the once-reliable bullpen falters despite Jansen’s presence. The team ranks second in blown saves and last in win probability. In contrast, Cleveland enjoys a strong season, leading their division at 34-26, while Detroit languishes at 22-37, trailing by 11.5 games.
The rumor mill swirls around a potential Skubal trade. Ken Rosenthal from The Athletic indicates such a move is increasingly plausible. “The outlook is bleak,” Rosenthal commented during an MLB on FOX pregame broadcast. With a 14-game deficit, Detroit faces a daunting climb back to contention, intensifying trade speculations.
Currently on a post-surgery recovery track, Skubal aims for a mid-to-late June return to the mound. Should he regain form, the Tigers will have roughly a month before the trade deadline to assess his market value. Rosenthal notes considerable team interest, contingent on Skubal’s health. His progress involves throwing and facing hitters soon, thanks to innovative NanoNeedle elbow surgery.
According to MLB.com’s Mark Feinsand, various league executives anticipate a Skubal trade. One NL executive remarked on the potential urgency: “If they remain this far out of contention, they must prioritize organizational interests.” Speculation includes interest from teams such as the Los Angeles Dodgers, New York Yankees, Atlanta Braves, and even the Milwaukee Brewers, known for acquiring talent on expiring contracts.
Even amid his pending free agency, Skubal could attract a lucrative trade package. His potential impact on postseason play, should he return to his dominant form, makes him a coveted asset. Big-market teams might pursue him aggressively, hoping to negotiate an extension prior to free agency. Detroit faces the chance of securing such a top-tier performer, highlighting the premium placed on extraordinary talent in high-stakes games. Skubal’s next move holds intriguing possibilities as trade discussions continue.
Leave a Reply